Cosmos Health (COSM) Projects $6M Revenue from Oliv18 Launch
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowCosmos Health (COSM) anticipates $6 million in revenue from the launch of its Oliv18 supplement. This projection is part of the company’s growth strategy in the health and wellness sector. The launch of Oliv18 aims to leverage increasing consumer demand for dietary supplements. This expected revenue could positively influence investor sentiment and market performance for Cosmos Health.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
Related News
Alphabet (GOOGL) Shares Fall After Q2 Earnings Report
Oct 19
Aeromexico Plans New US Flights After Washington Lifts Restrictions
Oct 19
SpaceX AI Computing Power Rental Driving Revenue Growth but Raising Costs
Oct 19
S&P 500 and Nasdaq Rise as AI Stocks Rebound Before Earnings
Oct 19